Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
52 studies found for:    "Systemic candidiasis"
Show Display Options
Rank Status Study
1 Completed
Has Results
Anidulafungin Candidemia/Invasive Candidiasis Intensive Care Study
Condition: Invasive Candidiasis
Interventions: Drug: Anidulafungin;   Drug: Fluconazole;   Drug: Voriconazole
2 Terminated
Has Results
Risk Of Severe Hepatic Injury In Patients With Invasive Candidiasis Treated With Echinocandins
Conditions: Invasive Candidiasis;   Candidemia
Intervention: Other: Does not apply
3 Completed Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia
Conditions: Invasive Candidiasis;   Candidemia
Interventions: Drug: Micafungin;   Drug: fluconazole
4 Completed CRITIC - Treatment of Candidemia and Invasive Candidiasis
Conditions: Candidemia;   Invasive Candidiasis
Intervention: Drug: AmBisome
5 Completed
Has Results
β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients
Condition: Invasive Candidiasis
Interventions: Drug: Preemptive Therapy with Anidulafungin;   Drug: Empiric antifungal therapy based on physician discretion.
6 Terminated
Has Results
Pilot Feasibility Study With Patients Who Are at High Risk For Developing Invasive Candidiasis in a Critical Care Setting (MK-0991-067)
Condition: Invasive Candidiasis
Interventions: Drug: Caspofungin acetate;   Drug: Placebo
7 Completed
Has Results
This Is An Open-Label, Non-Comparative Study Designed To Evaluate A Short Course Of IV Anidulafungin, Followed Optionally By Oral Voriconazole, For The Treatment Of Candidemia And Invasive Candidiasis
Conditions: Candidemia;   Invasive Candidiasis
Interventions: Drug: Anidulafungin;   Drug: Voriconazole
8 Unknown  Invasive Candidiasis in ICU
Condition: Invasive Candidiasis
Intervention:
9 Active, not recruiting NOBICS - NOvel BIomarker In Invasive CandidiasiS/Candida Sepsis
Condition: Invasive Candidiasis
Intervention:
10 Completed
Has Results
Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)
Condition: Invasive Candidiasis
Interventions: Drug: Caspofungin;   Drug: Normal Saline
11 Recruiting Evaluate the Performance of Genetic Amplification by Polymerase Chain Reaction (PCR) and the "Mannan Antigenemia and Antimannan Antibodies Couple as a Means of Diagnosis and a Marker of Follow-up in Invasive Candidiasis.
Condition: Invasive Candidiasis; Treatment With Echinocandin
Interventions: Biological: Blood sample taken on the day the treatment is initiated;   Biological: Blood sample taken on day 3 after initiation of treatment;   Biological: Blood sample taken on day 5 after initiation of;   Biological: Blood sample taken on day 7 after initiation of treatment;   Biological: Blood sample taken on day 10 after initiation of treatment
12 Recruiting Pharmacokinetics of Micafungin in Critically Ill Patients
Conditions: Critical Illness;   Invasive Candidiasis
Intervention:
13 Completed Antimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell Transplantation
Conditions: Systemic Aspergillosis;   Systemic Candidiasis
Intervention:
14 Completed Pharmacokinetics of Anidulafungin on Intensive Care Unit (ICU)
Conditions: Invasive Candidiasis;   Critically Ill
Intervention:
15 Completed
Has Results
A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)
Condition: Invasive Candidiasis
Intervention: Drug: caspofungin acetate
16 Completed Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Conditions: Invasive Candidiasis;   Esophageal Candidiasis;   Oropharyngeal Candidiasis;   Candidemia
Intervention: Drug: Micafungin (Mycamine)
17 Completed Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the Drug
Conditions: Invasive Candidiasis;   Esophageal Candidiasis;   Oropharyngeal Candidiasis;   Candidemia
Intervention: Drug: Micafungin
18 Completed Optimal Dosage of Caspofungin in Critically Ill Patients
Conditions: Critically Ill;   Suspected Invasive Candidiasis
Intervention: Drug: Caspofungin
19 Unknown  Anidulafungin Pharmacokinetics in Intensive Care Unit Patients
Conditions: Invasive Candidiasis;   Candidemia
Intervention:
20 Completed Empirical Antifungal Treatment in ICUS
Condition: Invasive Candidiasis
Interventions: Drug: Micafungin;   Drug: PLACEBO

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years